22 results
8-K
SAVA
Cassava Sciences Inc
13 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:17pm
on behalf of the Company and of certain actions relating to fiduciary and other internal corporate matters; (6) adopt gender-neutral terms when referring
8-K
EX-99.1
y81 4nupid4l0zi92
8 Feb 21
Regulation FD Disclosure
4:09pm
8-K
EX-1.1
xqlq voax
13 Nov 20
Cassava Sciences Announces Proposed Public Offering of Common Stock
4:36pm
8-K
EX-99.1
ao2s5bfwfja6z69jq
14 Sep 20
Regulation FD Disclosure
4:01pm
8-K
EX-99.2
2j3m0 rfzm0
14 Sep 20
Regulation FD Disclosure
4:01pm
8-K
EX-99.1
rrx10yil
21 Apr 05
Pain Therapeutics Announces First Quarter 2005 Financial Results
12:00am
424B5
buor5ljp5w jvpw9um
8 Oct 04
Prospectus supplement for primary offering
12:00am
424B5
gdgeho712rh3177emcew
22 Sep 04
Prospectus supplement for primary offering
12:00am
424B1
xf9pj maa9ao
22 Sep 03
Prospectus with pricing info
12:00am